| Turkish Journal of Cancer |
| 2005, Volume 35, Number 3 |
| 21 article(s) found. |
Acute arterial thrombosis related to 5-fluorouracil and cisplatin combination chemotherapy regimen in an elderly patient
HÜSEYİN ENGİN, HÜSEYİN ABALI, SERCAN AKSOY, İSMAİL ÇELİK |
99mTc-MAG3/Renal Scintigraphy and Functional Parameters for the Evaluation of Cisplatin Nephrotoxicity
BELKIS ERBAŞ, HALUK ÖZEN, MURAT LEKİLİ, GÜNAYDIN ERBENGİ, COŞKUN BEKDİK |
Determination of Acute Cardiac Toxicity of Epirubicin By Continuous Ambulatory ECG Monitoring and Exercise Testing
BÜLENT ÜNDAR, MAHMUT KARAKUZU, MEHMET N. ALAKAVUKLAR, ÖNDER KIRIMLI, CAVİT ÇEHRELİ, MİTHAT ÖZER |
Cisplatin and five-day continuous infusion of 5-fluorouracil in patients with recurrent and disseminated cancer of the head and neck
İBRAHİM GÜLLÜ, GÜLTEN TEKUZMAN, EŞMEN BALTALI, AYŞE KARS, İBRAHİM BARIŞTA, NİLÜFER GÜLER, ÖZGÜR ÖZYILKAN, YAVUZ ÖZlŞIK, DİNÇER FIRAT |
High frequency audiometry and auditory brain stem response in ototoxicity of cisplatinum
SEMHA BERBEROĞLU1, BİLGEHAN BÖKE2, MÜNEVVER BÜYÜKPAMUKÇU1, FAİK SARIALİOĞLU1, CANAN AKYÜZ1, EROL BELGİN2 |
Phase II study of weekly doses of epirubicin in advanced breast cancer
DİNÇER FIRAT, EŞMEN BALTALI, FİKRİ İÇLİ, HALUK ONAT, NİL MANDEL, ÖNDER BERK, AHMET OBER, GÜRSEL AKTAN |
High dose epirubicin and ifosfamide alternating with etoposide and cisplatin therapy with granulocyte macrophage colony stimulating factor in small cell lung cancer
ÖNDER BERK1, HALUK ONAT2, AYŞE KARS3, SÜHEYLA SERDENGEÇTİ4, NAZAN GÜNEL5, FARUK AYKAN2, SAİT OKKAN4, MÜNİR KINAY6, NECDET ÜSKENT7, GÜRSEL AKTAN8, DİNÇER FIRAT3 |
Prevention of chemotherapy-induced emesis in patients with germ cell tumors receiving multiple-day cisplatin-based chemotherapy: efficacy and tolerability of tropisetron
HALUK ONAT, SEVİL E. İNANÇ, PINAR SAİP, ERKAN TOPUZ |
Weekly doses of epirubicin in locally advanced breast cancer patients as neoadjuvant chemotherapy
EŞMEN BALTALI, FİKRİ İÇLİ, NİL MOLİNAS MANDEL, HALUK ONAT, GÜRSEL AKTAN, AHMET OBER, NECDET ÜSKENT, MÜNİR KINAY,ÖNDER BERK, DİNÇER FIRAT |
Combination chemotherapy involving weekly epirubicin in the treatment of intermediate and high grade non-Hodgkin’s lymphomas
DİLEK DİNÇOL, NİL MANDEL MOLİNAS, İBRAHİM BARIŞTA, GÜRSEL AKTAN, HALUK ONAT, ORHAN SEYFİ SARDAŞ, ÖNDER BERK, CAVİT ÇEHRELİ, DİNÇER FIRAT |
A lethal tachycardia with wide-QRS complex during 5-fluorouracil therapy: a case report
SÜLEYMAN BÜYÜKBERBER1 CEMAL TUNCER2, İSMET AYDOĞDU1, MUSTAFA ŞAHİN3, SERVET SERBEST1 |
Cardiotoxicity of 5-fluorouracil: Two cases with severe bradycardia and review of the literature
MUSTAFA SAMUR1, ALİ ARICAN1, MEHTAP ÇAKIR2, ORHAN ŞENCAN1, AHMET DEMİRKAZIK1, HAKAN AKBULUT1, FİKRİ İÇLİ1 |
Gemcitabine and cisplatin in the treatment of patients with locally advanced and metastatic pancreatic carcinoma
MUSTAFA ALTINBAŞ1, METİN ÖZKAN1, ÖZLEM ER1, HASAN ŞENOL COŞKUN1, BÜNYAMİN KAPLAN2, CAN KÜÇÜK3, FEVZİ ALTUNTAŞ1, BÜLENT ESER1 |
Bioassay for determination of cisplatin activity in serum and urine
SHAHBAL B. KANGARLOO1, SUMAN B. GANGOPADHYAY1, STEFAN GLÜCK1, JOHANNES E.A. WOLFF1,2 |
Efficiency and tolerability of 5- fluorouracil-based adjuvant chemotherapy in elderly patients with colorectal carcinoma
İLHAN ÖZTOP1, ARZU YAREN1, IŞIL SOMALİ2, OKTAY TARHAN1, UĞUR YILMAZ1 |
The efficacy of two different dosages of epirubicin in neoadjuvant setting: FEC50 v.s. FEC100. Preliminary report
MUTLU DEMİRAY1, TÜRKKAN EVRENSEL1, ÖZKAN KANAT1, ENDER KURT1, MURAT ARSLAN1, ÖZLEM SARAYDAROLU2, İLKER ERCAN3, GÜZİN GÖNÜLLÜ1, ŞEHSUVAR GÖKGÖZ4, ŞAHSİNE TOLUNAY2, AYŞE GÖZKAMAN1, NALAN AKGÜL1, İSMET TAŞDELEN4, OSMAN MANAVOLU1 |
The efficacy of preoperative cisplatin and 5-fluorouracil combination in patients with stage III squamous cell carcinoma of the esophagus
SERDAR HAN1, BÜLENT YALÇIN2, HAKAN AKBULUT2, İLKER ÖKTEN3 |
Phase II study of gemcitabine plus epirubicin plus paclitaxel in metastatic breast cancer patients
MUTLU DEMİRAY1, TÜRKKAN EVRENSEL1, MURAT ARSLAN1, ÖZKAN KANAT1, ENDER KURT1, ÖZLEM SARAYDAROĞLU2, İLKER ERCAN3, ŞEHSUVAR GÖKGÖZ4, UĞUR TOPAL5, ŞAHSİNE TOLUNAY2, İSMET TAŞDELEN4, OSMAN MANAVOĞLU1 |
Vinorelbine and cisplatin in metastatic breast cancers
GÜZİN GÖNÜLLÜ, NEVZAT SELİM, İDRİS YÜCEL |
Evaluation of efficacy and toxicity of systemic chemotherapy of combined epirubicin, cisplatin and bolus 5- fluorouracil for hepatobiliary tumors
GÜZİN GÖNÜLLÜ1, TÜRKKAN EVRENSEL2, ENDER KURT2, MUTLU DEMİRAY2, MURAT ARSLAN2, ÖZKAN KANAT2, ABDULLAH ZORLUOĞLU3, OSMAN MANAVOĞLU2 |
The prevalence of silent arrhythmia in patients receiving cisplatin-based chemotherapy
ÖZLEM YAVAŞ1, KUDRET AYTEMİR2, İSMAİL ÇELİK1 |
|
Turkish Journal of Cancer web sitesi Novartis Onkoloji'nin karşılıksız eğitim katkılarıyla hazırlanmıştır.
|
